Annual EBITDA
-$10.51 M
+$755.00 K+6.70%
December 1, 2023
Summary
- As of February 7, 2025, PHIO annual EBITDA is -$10.51 million, with the most recent change of +$755.00 thousand (+6.70%) on December 1, 2023.
- During the last 3 years, PHIO annual EBITDA has fallen by -$1.79 million (-20.56%).
- PHIO annual EBITDA is now -44.36% below its all-time high of -$7.28 million, reached on December 31, 2018.
Performance
PHIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.59 M
+$323.00 K+16.88%
September 1, 2024
Summary
- As of February 7, 2025, PHIO quarterly EBITDA is -$1.59 million, with the most recent change of +$323.00 thousand (+16.88%) on September 1, 2024.
- Over the past year, PHIO quarterly EBITDA has increased by +$1.14 million (+41.74%).
- PHIO quarterly EBITDA is now -8.02% below its all-time high of -$1.47 million, reached on September 30, 2018.
Performance
PHIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$7.41 M
+$1.14 M+13.33%
September 1, 2024
Summary
- As of February 7, 2025, PHIO TTM EBITDA is -$7.41 million, with the most recent change of +$1.14 million (+13.33%) on September 1, 2024.
- Over the past year, PHIO TTM EBITDA has increased by +$4.06 million (+35.40%).
- PHIO TTM EBITDA is now -41.43% below its all-time high of -$5.24 million, reached on March 31, 2011.
Performance
PHIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PHIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | +41.7% | +35.4% |
| 3 y3 years | -20.6% | +41.7% | +35.4% |
| 5 y5 years | -44.4% | +41.7% | +35.4% |
PHIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.1% | at high | +55.3% | at high | +44.4% |
| 5 y | 5-year | -20.6% | +21.1% | at high | +57.3% | at high | +44.4% |
| alltime | all time | -44.4% | +49.6% | -8.0% | +88.9% | -41.4% | +70.8% |
Phio Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.59 M(-16.9%) | -$7.41 M(-13.3%) |
| Jun 2024 | - | -$1.91 M(-12.0%) | -$8.55 M(-6.4%) |
| Mar 2024 | - | -$2.17 M(+25.7%) | -$9.13 M(-13.1%) |
| Dec 2023 | -$10.51 M(-6.7%) | -$1.73 M(-36.6%) | -$10.51 M(-8.3%) |
| Sep 2023 | - | -$2.73 M(+9.2%) | -$11.47 M(-6.5%) |
| Jun 2023 | - | -$2.50 M(-29.7%) | -$12.26 M(+0.2%) |
| Mar 2023 | - | -$3.56 M(+32.5%) | -$12.24 M(+8.6%) |
| Dec 2022 | -$11.27 M(-15.4%) | -$2.68 M(-23.9%) | -$11.27 M(-5.3%) |
| Sep 2022 | - | -$3.52 M(+42.6%) | -$11.90 M(-1.6%) |
| Jun 2022 | - | -$2.47 M(-4.5%) | -$12.09 M(-1.6%) |
| Mar 2022 | - | -$2.59 M(-21.9%) | -$12.29 M(-7.7%) |
| Dec 2021 | -$13.32 M(+52.7%) | -$3.31 M(-10.9%) | -$13.32 M(+7.0%) |
| Sep 2021 | - | -$3.72 M(+39.5%) | -$12.45 M(+13.0%) |
| Jun 2021 | - | -$2.67 M(-26.4%) | -$11.02 M(+10.2%) |
| Mar 2021 | - | -$3.62 M(+48.1%) | -$10.00 M(+14.7%) |
| Dec 2020 | -$8.72 M(-2.2%) | -$2.44 M(+6.9%) | -$8.72 M(-2.3%) |
| Sep 2020 | - | -$2.29 M(+38.7%) | -$8.93 M(+2.2%) |
| Jun 2020 | - | -$1.65 M(-29.4%) | -$8.74 M(-4.3%) |
| Mar 2020 | - | -$2.34 M(-11.9%) | -$9.13 M(+2.4%) |
| Dec 2019 | -$8.92 M(+22.5%) | -$2.65 M(+26.5%) | -$8.92 M(+11.8%) |
| Sep 2019 | - | -$2.10 M(+2.8%) | -$7.98 M(+8.5%) |
| Jun 2019 | - | -$2.04 M(-4.1%) | -$7.36 M(+2.3%) |
| Mar 2019 | - | -$2.13 M(+24.2%) | -$7.19 M(-1.2%) |
| Dec 2018 | -$7.28 M(-47.9%) | -$1.71 M(+16.4%) | -$7.28 M(-3.4%) |
| Sep 2018 | - | -$1.47 M(-21.6%) | -$7.54 M(-11.5%) |
| Jun 2018 | - | -$1.88 M(-15.4%) | -$8.52 M(-6.8%) |
| Mar 2018 | - | -$2.22 M(+12.7%) | -$9.14 M(-34.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$13.99 M(+56.1%) | -$1.97 M(-19.8%) | -$13.99 M(-2.5%) |
| Sep 2017 | - | -$2.46 M(-1.7%) | -$14.35 M(+1.8%) |
| Jun 2017 | - | -$2.50 M(-64.7%) | -$14.10 M(+2.2%) |
| Mar 2017 | - | -$7.07 M(+203.8%) | -$13.80 M(+54.0%) |
| Dec 2016 | -$8.96 M(-11.8%) | -$2.33 M(+5.6%) | -$8.96 M(-3.0%) |
| Sep 2016 | - | -$2.20 M(+0.1%) | -$9.24 M(-3.0%) |
| Jun 2016 | - | -$2.20 M(-1.3%) | -$9.52 M(+0.6%) |
| Mar 2016 | - | -$2.23 M(-14.4%) | -$9.47 M(-6.8%) |
| Dec 2015 | -$10.16 M(+16.3%) | -$2.60 M(+4.8%) | -$10.16 M(+3.2%) |
| Sep 2015 | - | -$2.48 M(+15.9%) | -$9.84 M(+3.2%) |
| Jun 2015 | - | -$2.15 M(-26.7%) | -$9.54 M(+1.5%) |
| Mar 2015 | - | -$2.92 M(+27.9%) | -$9.40 M(+7.5%) |
| Dec 2014 | -$8.74 M(-58.1%) | -$2.29 M(+4.8%) | -$8.74 M(-2.3%) |
| Sep 2014 | - | -$2.18 M(+9.1%) | -$8.95 M(+1.6%) |
| Jun 2014 | - | -$2.00 M(-11.8%) | -$8.81 M(+0.7%) |
| Mar 2014 | - | -$2.27 M(-9.2%) | -$8.75 M(-58.0%) |
| Dec 2013 | -$20.85 M(+62.5%) | -$2.50 M(+22.0%) | -$20.85 M(+4.1%) |
| Sep 2013 | - | -$2.05 M(+5.6%) | -$20.04 M(+2.0%) |
| Jun 2013 | - | -$1.94 M(-86.5%) | -$19.65 M(-22.4%) |
| Mar 2013 | - | -$14.37 M(+753.7%) | -$25.33 M(+97.5%) |
| Dec 2012 | -$12.83 M(+1.8%) | -$1.68 M(+1.6%) | -$12.83 M(-5.6%) |
| Sep 2012 | - | -$1.66 M(-78.3%) | -$13.60 M(-3.3%) |
| Jun 2012 | - | -$7.62 M(+308.8%) | -$14.07 M(+52.3%) |
| Mar 2012 | - | -$1.86 M(-23.9%) | -$9.23 M(-26.8%) |
| Dec 2011 | -$12.61 M | -$2.45 M(+15.3%) | -$12.61 M(+24.1%) |
| Sep 2011 | - | -$2.13 M(-23.9%) | -$10.16 M(+26.5%) |
| Jun 2011 | - | -$2.79 M(-46.7%) | -$8.03 M(+53.3%) |
| Mar 2011 | - | -$5.24 M | -$5.24 M |
FAQ
- What is Phio Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual EBITDA year-on-year change?
- What is Phio Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Phio Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals TTM EBITDA year-on-year change?
What is Phio Pharmaceuticals annual EBITDA?
The current annual EBITDA of PHIO is -$10.51 M
What is the all time high annual EBITDA for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual EBITDA is -$7.28 M
What is Phio Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, PHIO annual EBITDA has changed by +$755.00 K (+6.70%)
What is Phio Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of PHIO is -$1.59 M
What is the all time high quarterly EBITDA for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly EBITDA is -$1.47 M
What is Phio Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, PHIO quarterly EBITDA has changed by +$1.14 M (+41.74%)
What is Phio Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of PHIO is -$7.41 M
What is the all time high TTM EBITDA for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high TTM EBITDA is -$5.24 M
What is Phio Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, PHIO TTM EBITDA has changed by +$4.06 M (+35.40%)